375 related articles for article (PubMed ID: 38426087)
1. Immune escape and metastasis mechanisms in melanoma: breaking down the dichotomy.
Shirley CA; Chhabra G; Amiri D; Chang H; Ahmad N
Front Immunol; 2024; 15():1336023. PubMed ID: 38426087
[TBL] [Abstract][Full Text] [Related]
2. Cancer Cell Phenotype Plasticity as a Driver of Immune Escape in Melanoma.
Benboubker V; Boivin F; Dalle S; Caramel J
Front Immunol; 2022; 13():873116. PubMed ID: 35432344
[TBL] [Abstract][Full Text] [Related]
3. Immunosuppressive cells in tumor immune escape and metastasis.
Liu Y; Cao X
J Mol Med (Berl); 2016 May; 94(5):509-22. PubMed ID: 26689709
[TBL] [Abstract][Full Text] [Related]
4. ZEB1 transcription factor promotes immune escape in melanoma.
Plaschka M; Benboubker V; Grimont M; Berthet J; Tonon L; Lopez J; Le-Bouar M; Balme B; Tondeur G; de la Fouchardière A; Larue L; Puisieux A; Grinberg-Bleyer Y; Bendriss-Vermare N; Dubois B; Caux C; Dalle S; Caramel J
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35288462
[TBL] [Abstract][Full Text] [Related]
5. The Genetic Basis of Dormancy and Awakening in Cutaneous Metastatic Melanoma.
Janowska A; Iannone M; Fidanzi C; Romanelli M; Filippi L; Del Re M; Martins M; Dini V
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565234
[TBL] [Abstract][Full Text] [Related]
6. Rethinking the biology of metastatic melanoma: a holistic approach.
Vandyck HH; Hillen LM; Bosisio FM; van den Oord J; Zur Hausen A; Winnepenninckx V
Cancer Metastasis Rev; 2021 Jun; 40(2):603-624. PubMed ID: 33870460
[TBL] [Abstract][Full Text] [Related]
7. Epithelial-to-mesenchymal-like transition events in melanoma.
Pedri D; Karras P; Landeloos E; Marine JC; Rambow F
FEBS J; 2022 Mar; 289(5):1352-1368. PubMed ID: 33999497
[TBL] [Abstract][Full Text] [Related]
8. Immunological Consequences of Epithelial-Mesenchymal Transition in Tumor Progression.
Chockley PJ; Keshamouni VG
J Immunol; 2016 Aug; 197(3):691-8. PubMed ID: 27431984
[TBL] [Abstract][Full Text] [Related]
9. Myeloid derived suppressor cells and the release of micro-metastases from dormancy.
Khadge S; Cole K; Talmadge JE
Clin Exp Metastasis; 2021 Jun; 38(3):279-293. PubMed ID: 34014424
[TBL] [Abstract][Full Text] [Related]
10. The role of lncRNAs in the tumor microenvironment and immunotherapy of melanoma.
Zhou W; Xu X; Cen Y; Chen J
Front Immunol; 2022; 13():1085766. PubMed ID: 36601121
[TBL] [Abstract][Full Text] [Related]
11. Systemic treatments for metastatic cutaneous melanoma.
Pasquali S; Hadjinicolaou AV; Chiarion Sileni V; Rossi CR; Mocellin S
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011123. PubMed ID: 29405038
[TBL] [Abstract][Full Text] [Related]
12. Epithelial-to-Mesenchymal Transition Gene Signature in Circulating Melanoma Cells: Biological and Clinical Relevance.
Rapanotti MC; Cugini E; Campione E; Di Raimondo C; Costanza G; Rossi P; Ferlosio A; Bernardini S; Orlandi A; De Luca A; Bianchi L
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511550
[TBL] [Abstract][Full Text] [Related]
13. Role of myeloid-derived suppressor cells in metastasis.
Cole K; Pravoverov K; Talmadge JE
Cancer Metastasis Rev; 2021 Jun; 40(2):391-411. PubMed ID: 33411082
[TBL] [Abstract][Full Text] [Related]
14. Wnt-signaling enhances neural crest migration of melanoma cells and induces an invasive phenotype.
Sinnberg T; Levesque MP; Krochmann J; Cheng PF; Ikenberg K; Meraz-Torres F; Niessner H; Garbe C; Busch C
Mol Cancer; 2018 Feb; 17(1):59. PubMed ID: 29454361
[TBL] [Abstract][Full Text] [Related]
15. Gene co-expression and histone modification signatures are associated with melanoma progression, epithelial-to-mesenchymal transition, and metastasis.
Azevedo H; Pessoa GC; de Luna Vitorino FN; Nsengimana J; Newton-Bishop J; Reis EM; da Cunha JPC; Jasiulionis MG
Clin Epigenetics; 2020 Aug; 12(1):127. PubMed ID: 32831131
[TBL] [Abstract][Full Text] [Related]
16. Human and mouse melanoma cells recapitulate an EMT-like program in response to mesenchymal stromal cells secretome.
de Souza LEB; Ferreira FU; Thome CH; Brand H; Orellana MD; Faça VM; Fontes AM; Covas DT
Cancer Lett; 2021 Mar; 501():114-123. PubMed ID: 33383153
[TBL] [Abstract][Full Text] [Related]
17. Molecular Aspects of FKBP51 that Enable Melanoma Dissemination.
D'Angelillo A; Staibano S; Russo M; Romano MF; Romano S
Curr Mol Pharmacol; 2015; 9(2):141-7. PubMed ID: 25986563
[TBL] [Abstract][Full Text] [Related]
18. The Kraken Wakes: induced EMT as a driver of tumour aggression and poor outcome.
Redfern AD; Spalding LJ; Thompson EW
Clin Exp Metastasis; 2018 Apr; 35(4):285-308. PubMed ID: 29948647
[TBL] [Abstract][Full Text] [Related]
19. Tumor Immune Microenvironment during Epithelial-Mesenchymal Transition.
Taki M; Abiko K; Ukita M; Murakami R; Yamanoi K; Yamaguchi K; Hamanishi J; Baba T; Matsumura N; Mandai M
Clin Cancer Res; 2021 Sep; 27(17):4669-4679. PubMed ID: 33827891
[TBL] [Abstract][Full Text] [Related]
20. Melanoma cell-derived exosomes promote epithelial-mesenchymal transition in primary melanocytes through paracrine/autocrine signaling in the tumor microenvironment.
Xiao D; Barry S; Kmetz D; Egger M; Pan J; Rai SN; Qu J; McMasters KM; Hao H
Cancer Lett; 2016 Jul; 376(2):318-27. PubMed ID: 27063098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
